Abstract Hyaluronic acid is the major glycosaminoglycan of the early cardiac extracellular matrix or "cardiac jelly," yet little is known about its role in the ontogeny of early ventricular performance. To investigate the in situ effect of hyaluronate degradation on ventricular function, whole rat embryos were cultured in rat serum alone (control embryos) or rat serum plus 20 TRU/mL of Streptomyces hyaluronidase (treatment embryos) from gestational day 9.5 (before formation of the heart tube) through initial looping of the heart. Cardiac function was measured before looping (24 hours in culture) and immediately after looping (36 hours in culture) by video motion analysis of the external wall motion of the bulbus cordis and primitive ventricle. Degradation of hyaluronic acid in the treated embryos was confirmed by Alcian blue staining at pH 2.5. Significant increases in heart rate, circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation were observed with looping in both control and treatment embryos. Although there was minimal difference in ventricular H _ . 'yaluronic acid metabolism is thought to play a central role in the normal development of several tissues' and has been implicated as a critical component of such major morphogenic events as neurulation2-4 and looping of the heart.56 Hyaluronic acid is the major glycosaminoglycan of the cardiac extracellular matrix or "cardiac jelly,"7'8 and many experiments delineating the role of hyaluronate in cardiac morphogenesis have focused primarily on structural phenomena such as early atrioventricular valve formation9 12 and early cardiac shape.13"4 These reports have used in vitro avian model systems almost exclusively.
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Unlike most other organ systems in the developing embryo, structural morphogenesis of the heart must be accompanied by the development of sufficient cardiac function for the embryo to maintain viability. However, to our knowledge there have been no previous investigations of the influence of hyaluronate or any other extracellular matrix component on ventricular performance in the embryonic heart. The purpose of our experiments was to quantify the in situ effect of hyaluronate degradation on early cardiac function in cultured whole rat embryos before and immediately after initial looping of the heart to begin to assess the role of normal extracellular matrix accumulation in the development of early embryonic ventricular function.
Materials and Methods

Whole-Embryo Culture
Wistar rat embryos were explanted in Tyrode's saline on gestational day 9.5 (positive vaginal smear is considered day 0). At this stage (0 to 3 somites), the neural folds have begun to develop, but the primitive heart tube has not yet formed. After removal of the decidual mass and opening of Reichert's membrane, embryos were placed in roller bottles containing heat-inactivated rat serum and cultured under a gas phase of 90% N2/5% 02/5% CO2 according to the method of New.'5 Control embryos were cultured in rat serum alone, and treatment embryos were cultured in rat serum plus 20 TRU/mL of Streptomyces hyaluronidase (Calbiochem), an enzyme that specifically degrades hyaluronic acid6"17 but does not adversely affect embryonic viability or development at this concentration.18 Prelooped embryos were evaluated as described below after an average of 24 hours in culture (5 to 7 somites), and postlooped embryos were similarly evaluated after an average of 36 hours in culture (13 to 15 somites). An additional group of control and treatment embryos were cultured for 48 to 72 hours and evaluated for the presence or absence of endocardial cushion formation.
Histological Preparation
To determine the extent of hyaluronic acid degradation, embryos were fixed in Carnoy's solution containing 0.5% FIG 1 . Schematic representation of the system used to quantify ventricular function in situ. Embryos were viewed under a dissecting microscope at x100 and x200 magnification, and cardiac contractions were recorded on videotape under thermostatically controlled conditions. A video motion detector was then used to measure external linear wall motion (amplitude of contraction) at each edge of the bulbus cordis (B) and primitive ventricle (V) before looping (straight heart tube, 24 hours in culture) and immediately after looping (initial looping, 36 hours in culture). This signal was then electronically differentiated to provide measurement of maximum velocity of contraction and maximum velocity of relaxation at the same positions on the embryo.
cetylpyridinium chloride and embedded in paraffin. Serial sections through both prelooped and postlooped hearts were stained with Alcian blue at pH 2.5, conditions that stain hyaluronic acid as well as other polyanions. 7, 19, 20 To ensure extensive removal of hyaluronic acid in the treated embryos, selected serial sections through the heart were secondarily incubated in Streptomyces hyaluronidase (100 TRU/mL) for 6 hours at 37°C, similarly stained with Alcian blue at pH 2.5, and evaluated for attenuation of staining when compared with similar sections that had not been secondarily incubated with enzyme. 21 
Measurement of Ventricular Function
Our system for measuring ventricular function is schematically diagramed in Fig 1. Both prelooped and postlooped embryos were removed from culture and placed in Tyrode's salt solution thermostatically controlled at 37.5±0.5°C by a stage warming/cooling device (Sensor Tech). Embryos were placed into a shallow depression made in a 9% agar solution, which permitted the embryos to be oriented in a standard fashion and confined the embryos to the microscopic field. Care was taken to ensure that only the posterior aspect and not the lateral or anterior aspects of the embryo came in contact with the agar solution, thus ensuring that there was no mechanical interference with cardiac contractions. Videotapes of cardiac activity were made at magnifications of x 100 and x200 by use of a Wild M5 microscope, transmitted light, and a closed-circuit high-resolution video camera (Dage-MTI, Newvicon tube), in conjunction with a 1/2-in videotape recorder (Panasonic). All images were electronically processed to produce maximal contrast. External ventricular wall motion was then measured from the videotapes with a video motion detector (model 633, Colorado Video), which monitors the position of the selected target along a single raster line at the field rate of the video signal (30 frames per second). A similar system has been used to quantify contractile properties of individual cells in culture. 22, 23 For every contraction, the ventricular wall motion, from the onset of contraction through the completion of relaxation, was converted every 33 milliseconds to a voltage signal proportional to the amplitude of contraction. The voltage signal from the video motion detector was filtered (7 Hz, low pass) and calibrated to yield the amplitude of contraction in micrometers. The signal was then electronically differentiated to provide the velocity of contraction and relaxation (micrometers per second). Amplitude and velocity were displayed on a multichannel recorder at a paper speed of 25 mm/s, from which heart rate, amplitude, maximum velocity of contraction, and maximum velocity of relaxation could be measured. Expressing fiber shortening, velocity of contraction, and velocity of relaxation in terms of resting fiber length (diastolic circumference) allows ventricles of different sizes to be directly compared, as is routinely done in clinical M-mode echocardiography. Unlike the echocardiographic conventions, our measurements are taken from the epicardial rather than the endocardial surface for the following reasons: In the mature heart, myocardium is the thickest component of the ventricular wall, and both endocardium and epicardium are closely apposed to it. The endocardial surface is conventionally used because it is more precisely indicated by ultrasound.24 The embryonic ventricular wall is dominated by the cardiac jelly, and the thin myoepicardial mantle is substantially removed from the endocardium. In addition, our videomicroscopy apparatus produces better images of the epicardial border. Epicardial measurements are therefore both more physiologically meaningful (with regard to myocardial performance) and more accurate in this system. Determinations were made for five consecutive beats and averaged to yield a single value for each parameter to reduce beat-to-beat variability.
Statistical Analysis
The present study was designed to compare three measurements of ventricular function (circumferential shortening, velocity of contraction, and velocity of relaxation) between control embryos and those treated with hyaluronidase. To determine potential influences of developmental stage (prelooped and postlooped) and measurement location (bulbus cordis and primitive ventricle) on the effects of hyaluronidase treatment, a three-factor ANOVA (looping, treatment status, and location) with repeated measures on one of the factors (location) was used, with Bonferroni's correction for multiple comparisons using an overall significance level of Pc.O5. Variables that could potentially confound the effect of hyaluronidase treatment on ventricular function (heart rate and diastolic diameter) were evaluated by multiple-regression techniques. In addition, the nonnal relations (ie, in control embryos) of ventricular function to measurement site and developmental stage were examined using twofactor and repeated-measures ANOVA.
Results
Histological Demonstration of Hyaluronic Acid Degradation
Our initial measurements of ventricular function were made before the onset of cardiac looping (24 hours in culture). Fig 2 shows photomicrographs of representative cross sections through the hearts of prelooped control and treatment embryos stained with Alcian blue. In the control embryo (Fig 2a) , the myocardium and endocardium are separated by extracellular matrix. Condensations of matrix components appear black. In the treatment embryo (Fig 2b) , the extracellular matrix has been obliterated, and the endocardium and myocardium are directly apposed with no appreciable accumulation of hyaluronic acid. Secondary incubation of similar sections showed marked attenuation of Alcian blue staining in the control embryos but no attenuation in a the treatment embryos (not shown). Thus, 24 hours of culture in Streptomyces hyaluronidase produced a significant reduction in hyaluronic acid content of the early cardiac extracellular matrix.
Postlooped ventricular function was assessed after 36 hours in culture, and Fig 3 shows selected photomicrographs of cardiac cross sections from control and treatment embryos at this stage. In the control embryo (Fig  3a) , the myocardium and endocardium are separated by an extracellular matrix rich in hyaluronic acid, as denoted by the black-stained material. In the treated embryo (Fig  3b) , there has been extensive removal of hyaluronic acid and subsequent collapse of the extracellular matrix. As with the prelooped hearts, there was no attenuation of Alcian blue staining after secondary enzyme incubation (not shown). These findings confirm significant hyaluronic acid degradation throughout the period of development in which ventricular performance was assessed.
Endocardial cushion formation was absent in all Streptomyces hyaluronidase-treated embryos examined at 36 hours. To determine whether endocardial cushion formation was inhibited or merely delayed, an additional group of seven treatment and seven control embryos was cultured for 48 to 72 hours and evaluated for effects on endocardial cushion formation. . The widely patent atrioventricular canal (AVC) is seen through the thin-walled heart of the embryo separating the atria (A) and ventricle (V/). Bright-field photomicrographs of Alcian blue-stained (pH 2.5) cross sections through the AVC region of a control (c) and Streptomyces hyaluronidase-treated embryo (f) are shown. In the control embryo (cultured for 60 hours), there is regional accumulation of hyaluronate-rich extracellular matrix in the AVC region characteristic of normal endocardial cushion (EDC) formation. However, in the embryo treated with Streptomyces hyaluronidase for 72 hours, degradation of hyaluronic acid has resulted in inhibition of EDC formation. Bar=50 gim.
4e shows right and left lateral views of an embryo cultured for 72 hours in the presence of Streptomyces hyaluronidase. The widely patent atrioventricular canal is easily appreciated through the thin wall of the embryonic heart. A cross section through the atrioventricular canal region stained with Alcian blue (pH 2.5) demonstrates a markedly reduced extracellular matrix and inhibition of endocardial cushion formation. In contrast, Alcian blue-stained cross sections through a control embryo after 60 hours in culture (Fig 4c) demonstrate the regional accumulation of hyaluronic acid in the atrioventricular canal characteristic of normal endocardial cushion formation. All treatment embryos examined failed to demonstrate significant endocardial cushion formation despite a prolonged culture period of 48 to 72 hours.
Measurements of Ventricular Function
Videotape recordings suitable for analysis were obtained from a total of 45 embryos. Values of heart rate, diastolic circumference, circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation at the bulbus cordis and primitive ventricle are indicated in the Heart rate and diastolic circumference of prelooped and postlooped embryos treated with hyaluronidase did not differ significantly from the corresponding measurements of control embryos. Fig 6 compares circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation between control and hyaluronidase-treated embryos at the prelooped and postlooped stages. Measurements from the bulbus cordis and primitive ventricle are combined in this figure because multifactor ANOVA showed no effect of measurement site on any of these measurements in either treatment group. Significant (P<.001) differences between control and hyaluronidase-treated embryos were observed in all three measurements after cardiac looping. Differences between control and hyaluronidase treatment in prelooped embryos were of much lesser magnitude and of marginal statistical significance (P=.06 to .11).
Multiple-regression techniques were used to determine the extent to which differences in heart rate or diastolic diameter may have contributed to the observed differences in circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation between control and hyaluronidase-treated embryos. After adjustment for heart rate, diastolic diameter, developmental stage, and measurement location, highly significant (P<.0001) differences between control and hyaluronidase-treated embryos persisted in circumferential shortening fraction, maximum velocity of circumferential contraction, and maximum velocity of circumferential relaxation.
Discussion Developmental Changes in Control Embryos
Cardiac looping was associated with pronounced increases in heart rate, circumferential shortening fraction, and circumferential velocities of contraction and relaxation. Although substantial longitudinal growth of the bulbus cordis and ventricle occurs during cardiac looping, we did not observe any substantial increase in diastolic diameter. The quantitative improvement in systolic and diastolic ventricular performance described in the present study is developmentally coincident with a qualitative change from quasi-peristaltic to coordinated ventricular contraction. 25 We speculate that the increased heart rate and improved ventricular function of the postlooped embryonic heart permit it to meet the increased hemodynamic needs of the embryo, which is growing substantially faster than its heart. The heart rate values we observed agree closely with those obtained by others at similar stages of development. [26] [27] [28] Because there is no functional autonomic innervation at this stage of embryonic cardiac development, alterations in heart rate are a reflection of embryonic maturity, viability, and culture conditions (ie, temperature). Our heart rate measurements therefore indicate that our experimental conditions were adequate to permit collection of meaningful cardiovascular data. Ventricular performance is determined by heart rate, afterload (impedance to ventricular ejection), preload (end-diastolic myocardial tension), and myocardial contractility. investigated. These findings, along with the normal heart rates we observed, would suggest that our cultured embryos are reasonably representative of embryos in utero. Use of cultured embryos is also justified by the fact that measurements of cardiac function (other than heart rate) and enzyme treatment cannot be successfully accomplished in utero at these developmental stages. Our measurements of wall motion were made at the external border of the myoepicardial mantle because it is more clearly visualized and because epicardial ventricular measurements have been shown to accurately reflect ventricular mass and function in the embryonic heart.31 However, if values could be obtained from the subendocardial border of the myocardium, they would vary little from those we report, because the myocar- dium is less than five cells thick at these stages. Clearly, if measurements could be reliably obtained from the endocardium, which is widely separated from the myoepicardial mantle by the cardiac jelly, they would be substantially less representative of myocardial function, although such measurements could be used to determine stroke volume or ejection fraction.
In addition to circumferential shortening, we chose to measure and report maximum velocities of circumferential contraction and relaxation to further characterize ventricular function in these embryos. Technically, the frame rate of our video recordings (30 Hz) is not sufficiently high to guarantee that true maximum velocities were obtained. However, the frame rate of our technique is comparable to radionuclide angiography (16 to 20 Hz) or angiocardiography (15 to 30 Hz) and is substantially better than mean velocity of circumferential fiber shortening as determined by echocardiography. Most reassuring is the fact that, when we averaged the values for five consecutive beats for each embryo, coefficients of variation were typically <5%, indicating that the velocities were within the range that could be reliably measured by our system. Despite these limitations, our experiments represent the first effective measurement of cardiac function in the rat before day 12 of gestation. Nakazawa and colleagues32,33 have measured arterial blood pressure in excised day-11 to -15 rat embryos within the uterus, but the low heart rates recorded before day 12 Hyaluronidase treatment of cultured embryos effectively removed hyaluronic acid from the heart, resulting in loss of the cardiac jelly from the ventricle and the endocardial cushions (Figs 2 through 4) . Although previous reports from this laboratory, as well as others, have suggested that hyaluronic acid is not essential for in situ neural tube closure18 or heart "looping" in the rat,41 the results presented here suggest that hyaluronic acid has an important influence on normal ventricular function in the early rat embryo. We observed striking effects of hyaluronidase treatment on ventricular function in postlooped embryos. In prelooped embryos, hyaluronidase produced lesser effects that failed to achieve statistical reduces ventricular wall thickness, stroke volume should be increased in treated embryos even if (external) circumferential shortening is unchanged.
Heart rate and diastolic diameter (preload) did not account for the observed differences between hyaluronidase-treated and control embryos on multipleregression analysis. Furthermore, the similarity in heart rates between control and hyaluronidase-treated embryos implies that all embryos were observed under similar conditions. The increases in circumferential shortening and maximum velocity of circumferential contraction are therefore attributable to improved myocardial contractility, decreased afterload, or to a combination of both factors. The increase in maximum velocity of circumferential relaxation may reflect an improvement in myocardial relaxation but more likely represents increased ventricular compliance due to the absence of cardiac jelly. It is possible that hyaluronate degradation may have altered myocardial contractility or relaxation: cultured cardiomyocytes are altered by their mechanical substrate,42-44 and a transmembrane hyaluronic acid receptor that interacts with the actin cytoskeleton has been described in the lung.45'46 Nevertheless, any mechanism linking hyaluronic acid degradation to intrinsic myocardial function is speculative at this time.
Our observations suggest that altered afterload contributed to the effects of hyaluronidase treatment. From the onset of circulation (shortly after heart tube formation, during the looping process), blood flow is primarily unidirectional. Although true heart valves have not yet formed during the stages represented in our study, antegrade flow is provided by the valvelike action of endocardial cushions, which are extensive accumulations of extracellular matrix located at the atrioventricular junction and conotruncal outflow tract.47-50 As can be seen from Fig 4, hyaluronic acid degradation resulted in a dramatic reduction of endocardial cushion tissue in the atrioventricular canal region. Such impaired formation of the endocardial cushions should be accompanied by atrioventricular incompetence, allowing retrograde flow during contraction. This was indeed subjectively observed on review of our videotapes of postlooped treatment embryos. However, visualization of directional blood flow is difficult in these embryos, because the embryonic blood cells do not contain hemoglobin and are essentially transparent under the conditions described. Although the atria of hyaluronidase-treated embryos appeared enlarged, overlying structures prevented accurate measurement of atrial size. A decrease in afterload from atrioventricular incompetence would be sufficient to explain the observed increases in circumferential shortening and maximum velocity of circumferential contraction, as well as the lesser response to hyaluronic acid degradation in prelooped embryos. Before looping, the circulation is just beginning, the endocardial cushions are in the initial stage of formation, and ventricular contraction is quasi-peristaltic. 26 Hyaluronate degradation at this stage might not be expected to dramatically affect function, because the quasi-peristaltic nature of ventricular contraction would encourage unidirectional blood flow even in the absence of atrioventricular competence. However, after looping, the endocardial cushions play a significant hemodysignificance. However, because hyaluronidase treatment namic role, and deformation could result in the pertur-bations described. If the conotruncal cushions (which also are eliminated by hyaluronidase treatment) contribute to afterload or if vascular extracellular matrix contributes to vascular impedance, it is possible that hyaluronidase treatment could also reduce afterload by these mechanisms.
The observation that the endocardial cushions did not form in situ after treatment with hyaluronidase is consistent with previous in vitro observations. Bernanke and Markwald51 noted that addition of hyaluronic acid to the collagen gel bioassay of endocardial cushion formation resulted in at least a twofold increase in the epithelial-mesenchymal transformation of atrioventricular canal endothelial cells. Furthermore, extraction of extracellular matrix in the presence of hyaluronidase appeared to have an inhibitory effect on epithelial mesenchymal transformation in the same model.52 Our studies provide additional evidence that the presence of hyaluronic acid is required for normal endocardial cushion formation in vivo.
The separation of endocardium and myocardium by extracellular matrix in the embryonic heart results in physiological possibilities unique to the developing embryo, eg, the ability to increase end-diastolic ventricular volume without increasing end-diastolic ventricular diameter, as accomplished in the present study through degradation of the extracellular matrix. Decreased ventricular wall thickness through removal of the cardiac jelly alone, with no change in external dimension or circumferential shortening fraction, would result in an increase in stroke volume but a decrease in ejection fraction. In our postlooped embryos, diastolic diameter was unaffected by hyaluronidase treatment, but circumferential shortening increased. In this situation, we cannot determine whether ejection fraction was preserved, with a large increase in stroke volume, or whether ejection fraction decreased, but to a lesser extent than the increase in stroke volume. Some investigators have suggested that ejection fraction, stroke volume, and cardiac output can be derived from measurements of end-diastolic and end-systolic diameter by assuming that the embryonic ventricle maintains a stable configuration as a prolate ellipse.53 However, we have chosen not to make this assumption, since this approach has only been validated for mature hearts and does not take into consideration that the primitive ventricle is constantly changing geometry as it develops. Measurements of ventricular volume or ejection fraction, although not currently practical, would be helpful in more precisely describing the hemodynamic effects of hyaluronate degradation.
The observation that maximal velocity of circumferential relaxation increased after hyaluronic acid degradation in the postlooped embryos suggests that the diastolic relaxation of the embryonic ventricle is not "enhanced" by the physical characteristics of the cardiac jelly as has been previously thought.54 Furthermore, the increase in the indexes of ventricular performance observed confirms that even the primitive embryonic heart, which lacks innervation, is capable of hemodynamic compensation.37
Conclusions
We have described substantial increases that accompany cardiac looping in both systolic and diastolic function of the embryonic heart in the rat. These increases are observed in both major components of the embryonic ventricle (bulbus cordis and primitive ventricle) and appear to complement the previously reported increase in heart rate26-28 and improved coordination of contraction25 in the postlooped heart. We have also demonstrated that the presence of hyaluronic acid in the cardiac extracellular matrix is necessary for formation of the endocardial cushions and that its absence is associated with substantial hemodynamic alterations, especially in the postlooped heart. These experiments provide insights into the importance of hyaluronic acid accumulation in the ontogeny of normal cardiac function as well as structure. Our findings emphasize the necessity of assessing functional as well as morphological parameters to appreciate the role of the extracellular matrix in normal developmental processes.
